COVID-19 pill Paxlovid moves closer to full FDA approval
The medication has been used by millions of Americans since the FDA granted it emergency use authorization in late 2021.
The medication has been used by millions of Americans since the FDA granted it emergency use authorization in late 2021.
Democrats and Republicans mostly agreed Wednesday that scientists and the intelligence community should fully investigate the origins of COVID-19 without political interference over whether the virus emerged from nature or through a lab leak.
Continuing a trend in Indiana courts, the 7th Circuit Court of Appeals has once again ruled that COVID-related business closures do not qualify as “physical losses” eligible for insurance coverage.
The White House is calling for money and more time to prosecute cases, to put into place new ways to prevent identity theft and to help people whose identities were stolen.
Christopher Wray’s statement follows a Department of Energy analysis for a new government-wide intelligence assessment that a lab accident in Wuhan was most likely responsible for the deadly pandemic.
Nearly 30 million Americans who got extra government help with grocery bills during the pandemic will soon see that aid shrink—and there’s a big push to make sure they’re not surprised.
Many parts of downtown are thriving—particularly neighborhoods, where rents are rising, people have to stand in line for a lunch table, and investments are flowing. Other parts—especially downtown’s central core, where many workers might come to the office only once or twice a week—are limping along, pockmarked by vacant storefronts, panhandlers and crumbling sidewalks.
More than 1,000 people have pleaded guilty or have been convicted on federal charges of defrauding myriad COVID-19 relief programs that Congress established in the early days of the pandemic.
The costs of COVID-19 vaccines are expected to skyrocket after the emergencies are lifted. Free at-home COVID tests will also come to an end. And hospitals will not get extra payments for treating COVID patients.
The U.S. is poised to make COVID-19 vaccinations more like a yearly flu shot, a major shift in strategy despite a long list of questions about how to best protect against a still rapidly mutating virus.
The proposed change is designed to reduce the complexity of the vaccine regimen for the public, doctors and manufacturers. It also reflects a view that “chasing variants” with ever-changing booster formulations is ultimately futile.
The descendant of the omicron variant rose from barely 2 percent of U.S. cases at the start of December to more than 27 percent the first week of January, according to new estimates.
The Indiana Office of Technology, which purchases and distributes computers for state work, does not have an audit trail of the missing computers, an investigation found.
For working parents of young children, it seems the rest of the world has moved on from the pandemic. But unending illness and child care disruptions have upended these families’ lives.
The Associated Press has found that authorities around the world have used technologies and data used in the fight against COVID-19 to halt travel for activists and ordinary people, harass marginalized communities and link people’s health information to other surveillance and law enforcement tools.
The Food and Drug Administration’s decision aims to better protect the littlest children from severe COVID-19 at a time when children’s hospitals already are packed with tots suffering from a variety of respiratory illnesses.
The class-action lawsuit against Ball State University was filed by a student at the school last year. The legal challenge claims Ball State has refused to reimburse students for tuition and fees that were paid for in-person classes and services.
Employees at the world’s biggest Apple iPhone factory were beaten and detained in protests over pay amid anti-virus controls, according to witnesses and videos on social media Wednesday, as tensions mount over Chinese efforts to combat a renewed rise in infections.
The high demand for therapy is the latest sign of and ongoing U.S. mental health crisis exacerbated by the coronavirus pandemic. Though millions of Americans have returned to normal life, many people feel far from normal.
The test is the first over-the-counter test distributed in the U.S. by Roche Diagnostics, which has its North American headquarters in Indianapolis.